Page last updated: 2024-11-07

azauridine and Primary Myelofibrosis

azauridine has been researched along with Primary Myelofibrosis in 1 studies

Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.

Primary Myelofibrosis: A de novo myeloproliferation arising from an abnormal stem cell. It is characterized by the replacement of bone marrow by fibrous tissue, a process that is mediated by CYTOKINES arising from the abnormal clone.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mason, JE1
DeVita, VT1
Canellos, GP1

Other Studies

1 other study available for azauridine and Primary Myelofibrosis

ArticleYear
Thrombocytosis in chronic granulocytic leukemia: incidence and clinical significance.
    Blood, 1974, Volume: 44, Issue:4

    Topics: Anemia; Azauridine; Blood Cell Count; Blood Platelets; Bone Marrow Examination; Busulfan; Cell Trans

1974